Pfizer Inc.
PFE
$22.28
-$0.26-1.15%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/30/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -22.79% | 0.36% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -22.79% | 0.36% | |||
| Cost of Revenue | -54.86% | 17.88% | |||
| Gross Profit | -7.48% | -6.30% | |||
| SG&A Expenses | -38.57% | 52.02% | |||
| Depreciation & Amortization | -10.89% | 3.58% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -40.48% | 25.92% | |||
| Operating Income | 70.73% | -51.60% | |||
| Income Before Tax | 27,940.00% | -100.21% | |||
| Income Tax Expenses | 55.11% | -279.91% | |||
| Earnings from Continuing Operations | 623.36% | -90.83% | |||
| Earnings from Discontinued Operations | -- | 187.50% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 25.00% | 0.00% | |||
| Net Income | 623.66% | -90.82% | |||
| EBIT | 70.73% | -51.60% | |||
| EBITDA | 39.54% | -39.17% | |||
| EPS Basic | 623.10% | -90.82% | |||
| Normalized Basic EPS | 89.95% | -54.10% | |||
| EPS Diluted | 628.29% | -90.94% | |||
| Normalized Diluted EPS | 90.04% | -54.09% | |||
| Average Basic Shares Outstanding | 0.14% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.12% | -0.04% | |||
| Dividend Per Share | 2.38% | 0.00% | |||
| Payout Ratio | -0.86% | 9.89% | |||